INDVHIGH SIGNALFINANCIAL10-K

INDV showed dramatic financial improvement with net income surging from $2M to $210M while operating cash flow turned negative and share buybacks plummeted 94%.

The massive 10,400% increase in net income alongside 719% operating income growth suggests either a major one-time gain or significant operational turnaround, but the simultaneous collapse in operating cash flow from $36M to -$27M raises red flags about earnings quality. The dramatic reduction in share buybacks from $173M to $11M combined with declining cash reserves indicates management is conserving capital amid operational cash challenges.

Comparing 2026-02-26 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

INDV's financial profile shows a paradoxical picture where profitability metrics skyrocketed (net income up 10,400%, operating income up 719%) while cash generation deteriorated significantly (operating cash flow turned negative at -$27M). The balance sheet showed broad improvement with total liabilities declining 22% and stockholders equity deficit narrowing from -$348M to -$98M, but cash reserves fell 39% to $195M while capital expenditures more than doubled. This combination of surging reported profits but negative cash generation, coupled with reduced buyback activity and declining cash balances, suggests potential earnings quality issues that warrant immediate investor scrutiny.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+10400%
$2.0M$210.0M

Net income grew 10400% — bottom-line growth signals improving overall business health.

Operating Income
P&L
+718.8%
$32.0M$262.0M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Operating Cash Flow
Cash Flow
-175%
$36.0M-$27.0M

Operating cash flow fell 175% — earnings quality concerns; investigate working capital changes and non-cash items.

Capital Expenditure
Cash Flow
+127.6%
$29.0M$66.0M

Capital expenditure jumped 127.6% — major investment cycle underway; assess returns on deployment.

Share Buybacks
Cash Flow
-93.6%
$173.0M$11.0M

Buyback activity reduced 93.6% — capital being redeployed elsewhere or cash conservation underway.

Stockholders Equity
Balance Sheet
+71.8%
-$348.0M-$98.0M

Equity base grew 71.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Cash & Equivalents
Balance Sheet
-38.9%
$319.0M$195.0M

Cash declined 38.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Assets
Balance Sheet
-22.3%
$839.0M$652.0M

Current assets declined 22.3% — monitor working capital adequacy and short-term liquidity.

Total Liabilities
Balance Sheet
-22.1%
$1.7B$1.3B

Liabilities reduced 22.1% — deleveraging improves balance sheet strength and financial flexibility.

Inventory
Balance Sheet
-14%
$178.0M$153.0M

Inventory reduced 14% — lean inventory management or demand outpacing supply.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-03-03
ADDED
(Exact name of registrant as specified in its charter) Delaware 41-2520873 State or other jurisdiction of incorporation or organization (I.R.S.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
147 SIGNATURES 148 i GLOSSARY ANDA means an abbreviated new drug application filed with the FDA.
Aquestive means Aquestive Therapeutics, a third-party CMO that manufactures and supplies SUBOXONE Film exclusively for us.
BMAT means buprenorphine-medically assisted treatment, the process to treat OUD patients treated with Buprenorphine (as opposed to methadone or other medicines).
+7 more — sign up free →
REMOVED
As of March 1, 2025, the number of outstanding ordinary shares was 124,655,858 .
8 Overview 8 Industry Overview 12 Indivior Products 16 Competition 19 Research and Development 19 Pipeline 21 Manufacturing and Supply 21 Sales, Marketing and Distribution 23 Intellectual Property 28 Regulatory Overview 29 Environmental 42 Human Capital 43 Other Information and Corporate Governance 44 Item 1A.
162 Election of Directors 164 Family Relationships 168 Agreement with Significant Shareholder 168 Code of Ethics 168 Shareholder Nominations for Directors 168 Audit Risk Committee 169 Audit Committee Financial Expert 169 i Insider 170 Policies 170 Item 11.
171 Total Compensation for the Chair and Non-Executive Directors 171 Compensation of Executive Directors and Senior Managers 172 Annual Incentive Plan ( AIP ) 172 Indivior PLC Long-Term Incentive Plan ( LTIP ) 174 Indivior Share Plans 174 The Indivior 2024 Long-Term Incentive Plan (the LTIP ) 174 The Indivior 2024 U.K.
Savings Related Share Option Plan (the Sharesave Plan ) 178 The Indivior U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →